Sunshine Act Meetings, 23960 [2013-09652]

Download as PDF 23960 Federal Register / Vol. 78, No. 78 / Tuesday, April 23, 2013 / Notices Schedule Drug JWH–250 (6250) .......................... SR–18 also known as RCS–8 (7008). JWH–019 (7019) .......................... JWH–081 (7081) .......................... SR–19 also known as RCS–4 (7104). JWH–122 (7122) .......................... AM–2201 (7201) ........................... JWH–203 (7203) .......................... 2C–T–2 (7385) ............................. JWH–398 (7398) .......................... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 2C–D (7508) ................................. 2C–E (7509) ................................. 2C–H (7517) ................................. 2C–I (7518) .................................. 2C–C (7519) ................................. 2C–N (7521) ................................. 2C–P (7524) ................................. 2C–T–4 (7532) ............................. AM–694 (7694) ............................. Phenylacetone (8501) .................. NUCLEAR REGULATORY COMMISSION I I [NRC–2013–0001] Sunshine Act Meetings I I I AGENCY HOLDING THE MEETINGS: Nuclear Regulatory Commission. DATES: Weeks of April 22, 29, May 6, 13, 20, 27, 2013. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and Closed. I I I I I I I I I I I I I I I I I Week of April 22, 2013 Monday April 22, 2013 9:00 a.m. Meeting with the Department of Energy Office of Nuclear Energy (Public Meeting) (Contact: Brett Rini, 301–251–7615). This meeting will be webcast live at the Web address—www.nrc.gov. 2:30 p.m. Discussion of Management and Personnel Issues (Closed—Ex. 2 and 6). mstockstill on DSK4VPTVN1PROD with NOTICES The company plans to manufacture the listed controlled substances for distribution to their research and forensic customers conducting drug testing and analysis. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cayman Chemical Company to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cayman Chemical Company to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 16, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–09530 Filed 4–22–13; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 17:51 Apr 22, 2013 Jkt 229001 Tuesday April 23, 2013 9:00 a.m. Briefing on the Status of Lessons Learned from the Fukushima Dai’ichi Accident (Public Meeting) (Contact: William D. Reckley, 301–415–7490). This meeting will be webcast live at the Web address—www.nrc.gov. Week of April 29, 2013—Tentative There are no meetings scheduled for the week of April 29, 2013. Week of May 6, 2013—Tentative There are no meetings scheduled for the week of May 6, 2013. * The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings, call (recording)—301–415–1292. Contact person for more information: Rochelle Bavol, 301–415–1651. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., Braille, large print), please notify Kimberly Meyer, NRC Disability Program Manager, at 301–287–0727, or by email at kimberly.meyerchambers@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * This notice is distributed electronically to subscribers. If you no longer wish to receive it, or would like to be added to the distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969), or send an email to darlene.wright@nrc.gov. Dated: April 18, 2013. Rochelle C. Bavol, Policy Coordinator, Office of the Secretary. [FR Doc. 2013–09652 Filed 4–19–13; 4:15 pm] BILLING CODE 7590–01–P Week of May 13, 2013—Tentative There are no meetings scheduled for the week of May 13, 2013. REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION Week of May 20, 2013—Tentative [BAC 416404] Monday, May 20, 2013 9:30 a.m. Briefing on Human Capital and Equal Employment Opportunity (EEO) (Public Meeting) (Contact: Kristin Davis, 301–287– 0707). This meeting will be webcast live at the Web address—www.nrc.gov. Annual Public Meeting Week of May 27, 2013—Tentative Wednesday, May 29, 2013 9:00 a.m. Briefing on Results of the Agency Action Review Meeting (AARM) (Public Meeting) (Contact: Rani Franovich, 301–415–1868). This meeting will be webcast live at the Web address—www.nrc.gov. * * * * * PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 ACTION: Notice of annual meeting. The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is announcing an annual open public meeting. The Foundation will provide an overview of its history, project updates, as well as projected activities going forward. DATES: The open public meeting will be held on May 23, 2013, from 10 a.m. until 12 noon. Interested persons may sign up to attend in person and/or make comments at the meeting or submit written comments by visiting https:// SUMMARY: E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Page 23960]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09652]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2013-0001]


Sunshine Act Meetings

AGENCY HOLDING THE MEETINGS: Nuclear Regulatory Commission.

DATES: Weeks of April 22, 29, May 6, 13, 20, 27, 2013.

PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

STATUS: Public and Closed.

Week of April 22, 2013

Monday April 22, 2013

9:00 a.m. Meeting with the Department of Energy Office of Nuclear 
Energy (Public Meeting) (Contact: Brett Rini, 301-251-7615).

    This meeting will be webcast live at the Web address--www.nrc.gov.

2:30 p.m. Discussion of Management and Personnel Issues (Closed--Ex. 2 
and 6).

Tuesday April 23, 2013

9:00 a.m. Briefing on the Status of Lessons Learned from the Fukushima 
Dai'ichi Accident (Public Meeting) (Contact: William D. Reckley, 301-
415-7490).

    This meeting will be webcast live at the Web address--www.nrc.gov.

Week of April 29, 2013--Tentative

    There are no meetings scheduled for the week of April 29, 2013.

Week of May 6, 2013--Tentative

    There are no meetings scheduled for the week of May 6, 2013.

Week of May 13, 2013--Tentative

    There are no meetings scheduled for the week of May 13, 2013.

Week of May 20, 2013--Tentative

Monday, May 20, 2013

9:30 a.m. Briefing on Human Capital and Equal Employment Opportunity 
(EEO) (Public Meeting) (Contact: Kristin Davis, 301-287-0707).

    This meeting will be webcast live at the Web address--www.nrc.gov.

Week of May 27, 2013--Tentative

Wednesday, May 29, 2013

9:00 a.m. Briefing on Results of the Agency Action Review Meeting 
(AARM) (Public Meeting) (Contact: Rani Franovich, 301-415-1868).

    This meeting will be webcast live at the Web address--www.nrc.gov.
* * * * *
    * The schedule for Commission meetings is subject to change on 
short notice. To verify the status of meetings, call (recording)--301-
415-1292. Contact person for more information: Rochelle Bavol, 301-415-
1651.
* * * * *
    The NRC Commission Meeting Schedule can be found on the Internet 
at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.
* * * * *
    The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings, or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., Braille, large print), please notify Kimberly Meyer, NRC 
Disability Program Manager, at 301-287-0727, or by email at 
kimberly.meyer-chambers@nrc.gov. Determinations on requests for 
reasonable accommodation will be made on a case-by-case basis.
* * * * *
    This notice is distributed electronically to subscribers. If you no 
longer wish to receive it, or would like to be added to the 
distribution, please contact the Office of the Secretary, Washington, 
DC 20555 (301-415-1969), or send an email to darlene.wright@nrc.gov.

    Dated: April 18, 2013.
Rochelle C. Bavol,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2013-09652 Filed 4-19-13; 4:15 pm]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.